Philips (PHG) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $26.67B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | NL | CEO | Roy Jakobs |
| IPO Date | 1980-03-17 | CAGR | -0.66% |
| Employees | 66,401 | Website | www.philips.com |
| Div. Yield | 2.48% | Payout Ratio | 32% |
| Buy Back Yield | 0.18% | Total Yield | 2.66% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $29.85B | P/E | 15.59 | Forward P/E | 14.34 | PEG | 0.34 |
| P/S | 1.88 | P/B | 2.87 | P/CF | 14.38 | P/FCF | 17.67 |
| Sales | $20.12B | Sales 1Y | -1.08% | Sales 3Y | -3.84% | Sales 5Y | -7.22% |
| EPS | $1.75 | EPS 1Y | 582.35% | EPS 3Y | -152.02% | EPS 5Y | -1.55% |
| Sales QoQ | 11.65% | EPS QoQ | 150% | Sales QoQ Avg | 1.48% | EPS QoQ Avg | 45.2% |
| Gross Margin | 45.93% | Operating Margin | 10.17% | Profit Margin | 6.31% | ROCE | 9.32% |
| ROA | 4% | ROE | 10% | Altman Z Score | 2.05 | Piotroski Score | 7 |
| Current Ratio | 1.26 | Quick Ratio | 0.82 | Cash Ratio | 0.24 | Op. CF Ratio | 0.05 |
| Debt/Equity | 0.65 | Debt/Assets | 0.28 | Lt Debt/Equity | 0.55 | Lt Debt/Cap. | 0.36 |
| Intrst Cov. | 5.22 | Inventory Turnover | 2.97 | Asset Turnover | 0.66 | Receivables Turnover | 4.91 |
| Enterprise Value | $29.85B | P/E Ratio | 15.59 |
| Forward P/E | 14.34 | PEG Ratio | 0.34 |
| P/S Ratio | 1.88 | P/B Ratio | 2.87 |
| P/CF Ratio | 14.38 | P/FCF Ratio | 17.67 |
| EPS | $1.75 | EPS Growth 1Y | 582.35% |
| EPS Growth 3Y | -152.02% | EPS Growth 5Y | -1.55% |
| Revenue Growth 1Y | -1.08% | Gross Margin | 0.46% |
| Operating Margin | 0.1% | Profit Margin | 0.06% |
| ROE | 0.1% | ROA | 0.04% |
| ROCE | 0.09% | Current Ratio | 1.26 |
| Quick Ratio | 0.82 | Cash Ratio | 0.24 |
| Debt/Equity | 0.65 | Interest Coverage | 5.22 |
| Altman Z Score | 2.05 | Piotroski Score | 7 |
Philips (PHG) valuation & financials
Philips (PHG) has a market capitalization of $26.67B and trades at a price-to-earnings ratio of 15.6. It operates in the Healthcare sector (Medical - Devices).
Philips's revenue grew -1.1% over the last year.
Philips's next earnings report is scheduled for November 3, 2026 before market open; analysts estimate EPS of $0.41. Check the earnings calendar to see all companies reporting this week.
Philips (PHG) — frequently asked questions
When does Philips (PHG) report earnings next?
Philips is expected to report earnings on November 3, 2026 before market open. Analysts estimate EPS of $0.41.
What is Philips's market cap?
Philips (PHG) has a market capitalization of $26.67B.
What is PHG's P/E ratio?
Philips trades at a price-to-earnings ratio of 15.6, with trailing twelve-month EPS of $1.75.
How fast is Philips growing?
Philips's revenue grew -1.1% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)